The gift from the Knights will support continued growth and innovation in cardiac services at Providence, including the development of a heart transplant program at Providence in Oregon. Learn more ›
Search by keyword or filter by cancer type to learn more about the numerous clinical trials and research studies underway at Providence Cancer Center. Learn more ›
For Providence Health Plan members– Now there is a less expensive option for health care from the comforts of home. Just answer some questions online and get a diagnosis and treatment plan from a Providence provider within an hour. Try E-Visit ›
The Providence Smoking Cessation Program is designed to provide you with the tools necessary to stop smoking and begin living your best, healthiest life.
Learn how we’re committed to caring for all people and how we support social needs, such as safe housing, healthy food and mental health.
Providence is partnering with Catholic Charities of Oregon and the Archdiocese of Oregon in an ambitious plan by Catholic Charities USA to slash homelessness by 20 percent in Portland over five years.
Take a free health quiz to find out if you’re at risk for common health issues. In just a few minutes, you’ll get a personal health report, including recommendations on lifestyle changes.
Use Express Care Virtual to see a health care provider in minutes from your computer, smartphone or tablet.
The Earle A. Chiles Research Institute, a division of Providence Cancer Institute at the Robert W. Franz Cancer Center, offers several studies of targeted therapies, immunotherapies and combination therapies for patients...
Providence Medford Medical Center's steadfast commitment to excellent care has earned national recognition.
Providence Cancer Institute has announced Bryan Bell, D.D.S., M.D., is the new physician executive for surgical oncology research.
Providence registered dietitian and certified diabetes educator Becky McCarver contributed to a story in Kids' Health, a special Oregonian insert, about kids going back to school.
Patients who have relapsed or failed first-line treatment for aggressive forms of B-cell non-Hodgkin lymphoma may qualify to receive a promising CAR T-cell therapy in a new clinical trial at Providence Cancer Institute....